Nasal vs Injectable Testosterone
Nasal testosterone (Natesto) is a short-acting intranasal gel applied three times daily. Injectable testosterone (cypionate or enanthate) is the long-acting standard in modern TRT. The two differ in cadence, fertility impact, and biomarker stability.
Nasal testosterone is appropriate in select fertility-aware contexts and is not currently in the oMeds formulary.
Injectable testosterone is the modern default for most TRT candidates due to stable physiology and infrequent dosing.
Explore pathwayEducational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Does nasal preserve fertility?
Its short-action profile is less suppressive of the HPG axis than long-acting injectables.
Is adherence harder with nasal?
Three-times-daily dosing increases adherence burden compared with weekly injection.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment